These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32844322)

  • 1. Necroptotic-Apoptotic Regulation in an Endothelin-1 Model of Cerebral Ischemia.
    Dojo Soeandy C; Elia AJ; Cao Y; Rodgers C; Huang S; Elia AC; Henderson JT
    Cell Mol Neurobiol; 2021 Nov; 41(8):1727-1742. PubMed ID: 32844322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3.
    Vieira M; Fernandes J; Carreto L; Anuncibay-Soto B; Santos M; Han J; Fernández-López A; Duarte CB; Carvalho AL; Santos AE
    Neurobiol Dis; 2014 Aug; 68():26-36. PubMed ID: 24746856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
    Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
    J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1-mediated cerebral ischemia in mice: early cellular events and the role of caspase-3.
    Dojo Soeandy C; Salmasi F; Latif M; Elia AJ; Suo NJ; Henderson JT
    Apoptosis; 2019 Aug; 24(7-8):578-595. PubMed ID: 31073782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Neuronal Necroptosis Mediated by RIPK1 Provides Neuroprotective Effects on Hypoxia and Ischemia In Vitro and In Vivo.
    Mitroshina EV; Loginova MM; Yarkov RS; Urazov MD; Novozhilova MO; Krivonosov MI; Ivanchenko MV; Vedunova MV
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
    Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
    Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development.
    Zhang X; Dowling JP; Zhang J
    Cell Death Dis; 2019 Mar; 10(3):245. PubMed ID: 30867408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis.
    Takahashi N; Vereecke L; Bertrand MJ; Duprez L; Berger SB; Divert T; Gonçalves A; Sze M; Gilbert B; Kourula S; Goossens V; Lefebvre S; Günther C; Becker C; Bertin J; Gough PJ; Declercq W; van Loo G; Vandenabeele P
    Nature; 2014 Sep; 513(7516):95-9. PubMed ID: 25186904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin pretreatment reduces caspase-9 and RIPK1 protein activity in rat cardiac allograft ischemia-reperfusion.
    Tuuminen R; Holmström E; Raissadati A; Saharinen P; Rouvinen E; Krebs R; Lemström KB
    Transpl Immunol; 2016 Jul; 37():40-45. PubMed ID: 27155462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic preconditioning attenuates necroptotic neuronal death induced by global cerebral ischemia via Drp1-dependent signaling pathway mediated by CaMKIIα inactivation in adult rats.
    Zhan L; Lu Z; Zhu X; Xu W; Li L; Li X; Chen S; Sun W; Xu E
    FASEB J; 2019 Jan; 33(1):1313-1329. PubMed ID: 30148677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone Methyltransferase Dot1L Contributes to RIPK1 Kinase-Dependent Apoptosis in Cerebral Ischemia/Reperfusion.
    Wang J; Zhong W; Su H; Xu J; Yang D; Liu X; Zhu YZ
    J Am Heart Assoc; 2021 Dec; 10(23):e022791. PubMed ID: 34796721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
    Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
    Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
    Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
    Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis.
    Newton K; Wickliffe KE; Dugger DL; Maltzman A; Roose-Girma M; Dohse M; Kőműves L; Webster JD; Dixit VM
    Nature; 2019 Oct; 574(7778):428-431. PubMed ID: 31511692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
    Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
    Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis.
    Duprez L; Bertrand MJ; Vanden Berghe T; Dondelinger Y; Festjens N; Vandenabeele P
    J Biol Chem; 2012 Apr; 287(18):14863-72. PubMed ID: 22362767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
    Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
    Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.